Exchange: NASDAQ·Updated 06:22 PM EST

ARTL Artelo Biosciences Inc

$1.32
$0.06
(4.14%)
Today
Closed $1.39
$0.0712
(5.12%)
After Hours
Mkt Cap$1.3M
Vol51,962.00

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
18

Extremely Bearish Sentiment

How do you feel about ARTL?

johanroskam61
$ARTL Meer dan 6 fases 1 en 2 en Astra Zeneca is partner, overname is een feit bij goedkeuring, min. 50 dollar.
4
piedjie
$ARTL Can someone explain this to me? Premarket +6,5% and 2 minutes later it drops again. Insiders selling as soon as it rises? What’s the point?
1
1
johanroskam61
$ARTL Bij INO had ik ook gelijk, gaat hier ook gebeuren. Glaucoom is een markt van 13 miljard, uitstaande aandelen 500 K. Er is geen medicijn hiervoor , reken maar uit wanneer Artelo deze maand met goede test resultaten komt wat de koers gaat doen ? 100 plus.En verder.
2
Gunther77
$ARTL dilution has started and share price is mid $1. reverse split #6 is on it's way. Will it flounder until March? I don't know.
1
ma_Phoenix_am
$ARTL Probably multiple factors, capitulation, more shorts taking positions, insiders profit taking, and the good old fashion irrational market.
1
rk39842
$ARTL how many reverse split has this stock had in last year exactly...I see I am left with few token shares only ...who took my shares??
Gunther77
$ARTL down to $2.22. i feel that dilution coming. That puts them at 1.2m cap. How can they drop any lower? These guys are scamming hard. Three reverse splits in 2 years and several months away from another one.
Gunther77
$ARTL red on a green day, that's always a good sign. let's get this dilution over with so we can get onto better things.

Advertisement|Remove ads.